This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Duke University, Kuwait University. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2022
Title: Artak Tovmasyan: Innovator in Porphyrin Compounds
Introduction
Artak Tovmasyan is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of chemistry, particularly in the development of fluoro-substituted porphyrin compounds. With a total of 2 patents, Tovmasyan's work has implications in pharmaceuticals and cellular biology.
Latest Patents
Tovmasyan's latest patents include innovative methods and compounds. One patent focuses on fluoro-substituted porphyrin compounds, which are characterized by a structure where R is a C1-C8 alkyl substituted with at least one fluorine atom. This patent also details pharmaceutical compositions that utilize these compounds and methods for their preparation and application. Another significant patent involves a method for fluorescent staining of cellular and intracellular membranes. This method employs a fluorescent probe, specifically Zn(II) meso-tetrakis(N-n-hexylpyridinium-4-yl)porphyrin tetrachloride, which is designed to be non-toxic to cells and does not interfere with cell culture media.
Career Highlights
Throughout his career, Tovmasyan has worked with prestigious institutions, including Kuwait University and Duke University. His research has contributed to advancements in both academic and practical applications of porphyrin compounds.
Collaborations
Tovmasyan has collaborated with esteemed colleagues such as Ines Batinic-Haberle and Ludmil Tzvetanov Benov. These collaborations have further enriched his research and innovation in the field.
Conclusion
Artak Tovmasyan's contributions to the field of chemistry, particularly through his patents on porphyrin compounds, highlight his role as an influential inventor. His work continues to impact pharmaceutical applications and cellular research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
